Publications
467 publications
- Date
- Relevance
-
Prevention of panic disorders
Background reports show that for panic disorders sufficient scientific evidence exists for the efficacy of preventive ...
-
Abarelix (Plenaxis) for the treatment of advanced hormone-dependent prostate cancer
Data from two head-to-head trials showed that abarelix was not inferior to the GnHR-agonist leuprolide. The unintended effects of ...
-
Retigabine (Trobalt) for the adjunctive treatment of partial onset seizures with or without secondary generalisation in adults with epilepsy
As an adjunctive treatment for partial epilepsy, the therapeutic value of retigabine is comparable with that of gabapentin, ...
-
Background report on assessing established medical science and medical practice in repetitive transcranial magnetic stimulation (rTMS) in depression
The existing literature provides insufficient data to be able to decide whether there is a place for rTMS in the standard of care ...
-
Fluoride application on milk teeth
CVZ has carried out literature research into the question as to whether the professional application of fluoride to children who ...
-
Physical therapy and exercise in cases of chronic arthritis
CVZ concludes that there is no evidence for the efficacy of longterm physical therapy and exercise therapy in cases of chronic ...
-
Physical therapy and exercise in cases of osteoporosis
CVZ concludes that long-term physical therapy and exercise therapy for the indication “ vertebral fracture as a result of ...
-
Physical therapy and exercise in cases of arthrosis
CVZ concludes that there is no evidence for the efficacy of longterm physical therapy and exercise therapy in cases of chronic ...
-
Ticagrelor (Brilique) for the prevention of atherothrombotic events in adult patients with acute coronary syndromes
Patients treated with ticagrelor + ASA had a 22% reduced risk of all-cause mortality in comparison with patients treated with ...
-
Calcium acetate-magnesium carbonate (OsvaRen) for hyperphosphatemia
The Committee maintains her verdict that the therapeutic value of OsvaRen is comparable with that calcium acetate. This report is ...